Radioiodine ablation treatment induced pill esophagitis: A case report

Basit Öğe Kaydı
dc.authorscopusid50461202500
dc.authorscopusid55697472900
dc.authorscopusid8561324600
dc.authorscopusid35949526800
dc.authorscopusid54880546000
dc.authorscopusid56725133200
dc.authorscopusid57214923299
dc.contributor.authorElboğa, Umut
dc.contributor.authorDag, Muhammed Sait
dc.contributor.authorTutar, Ediz
dc.contributor.authorŞahin, Ertan
dc.contributor.authorKalender, Ebuzer
dc.contributor.authorDemir, Hasan Deniz
dc.contributor.authorÇelen, Y. Zeki
dc.date.accessioned2022-05-11T14:40:54Z
dc.date.available2022-05-11T14:40:54Z
dc.date.issued2015
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nükleer Tıp Ana Bilim Dalı
dc.description.abstractCapsule form of the drugs is more risk for pill-induced esophagitis. Radioiodine ablation is recommended for well differentiated thyroid cancer primary tumors >1 cm in diameter. In ablation, it is aimed to "ablate" the remaining healthy thyroid tissue. We present a case of a 23-year-old woman with complaints of severe odynophagia, dysphagia and retrosternal pain 3 days in which radioiodine ablation treatment was the cause of pill-induced esophagitis. She complained after she had undergone to radioiodine ablation treatment for papillary thyroid carcinoma. She had a history of swallowing I-131 capsule with about 150 ml water in the upright position. An upper endoscopic examination demonstrated two superficial kissing ulcers about 1 cm diameter in the middle of the esophagus. Pantoprazole and sucralfate treatment was started. Symptoms improved seven days after starting this treatment. The esophagus was completely normal in control endoscopy after two weeks. Radioiodine ablation treatment with I-131 capsule may cause esophageal lesions; therefore, patients should be educated by nuclear medicine physicians about the possible side effects of this treatment.
dc.identifier.endpage559
dc.identifier.issn0393-6384
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-84944280075
dc.identifier.scopusqualityN/A
dc.identifier.startpage557
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8956
dc.identifier.volume31
dc.indekslendigikaynakScopus
dc.institutionauthorŞahin, Ertan
dc.language.isoen
dc.publisherActa Medica Mediterranea
dc.relation.ispartofActa Medica Mediterranea
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPapillary thyroid carcinoma
dc.subjectPill esophagitis
dc.subjectRadioidine ablation treatment
dc.subjectiodine 131
dc.subjectlevothyroxine
dc.subjectliothyronine
dc.subjectpantoprazole
dc.subjectsucralfate
dc.subjectthyroglobulin
dc.subjectthyroid hormone
dc.subjectthyrotropin
dc.subjectadult
dc.subjectArticle
dc.subjectcancer diagnosis
dc.subjectcancer size
dc.subjectcancer surgery
dc.subjectcase report
dc.subjectdifferentiated thyroid cancer
dc.subjectdrug induced disease
dc.subjectdrug substitution
dc.subjectdrug withdrawal
dc.subjectdysphagia
dc.subjectendoscopic biopsy
dc.subjectesophagitis
dc.subjectesophagoscopy
dc.subjectesophagus ulcer
dc.subjectfemale
dc.subjecthistopathology
dc.subjecthuman
dc.subjectodynophagia
dc.subjectpalliative therapy
dc.subjectpill
dc.subjectpill induced esophagitis
dc.subjectpill induced esophagitis
dc.subjectradioisotope therapy
dc.subjectretrosternal pain
dc.subjectstanding
dc.subjectthyroglobulin blood level
dc.subjectthyroid carcinoma
dc.subjectthyroid papillary carcinoma
dc.subjectthyroidectomy
dc.subjectthyrotropin blood level
dc.subjecttumor ablation
dc.subjectyoung adult
dc.titleRadioiodine ablation treatment induced pill esophagitis: A case report
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
8956.pdf
Boyut:
473.58 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu